Pfizer (NYSE:PFE) announced positive results for a weight-loss drug candidate study but anticipates a profit decline due to…
Summary: Retatrutide is a promising GLP-1 drug with potential for weight loss and pain relief. Eli Lilly's revenue…
Sign in to your account